Evidence map›Paper›PMID 31485569›Full record

ArticleMayo Clinic proceedings. Innovations, quality & outcomes2019

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience.

Vidhu Anand, Robert P Frantz, Hilary DuBrock, Garvan C Kane, Michael Krowka, Ryoji Yanagisawa, Gurpreet S Sandhu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vidhu AnandDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Robert P FrantzDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Hilary DuBrockDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Garvan C KaneDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Michael KrowkaDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Ryoji YanagisawaKyorin University, Tokyo, Japan.
Gurpreet S SandhuDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the safety and efficacy of balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) seen at a US medical center. PATIENTS AND

methodsPatients with inoperable or residual postendarterectomy CTEPH who underwent BPA at Mayo Clinic in Rochester, Minnesota, between August 11, 2014, and May 17, 2018, were included. Invasive hemodynamic, clinical, laboratory, and echocardiographic data were collected and analyzed retrospectively.

resultsWe identified 31 patients (26 with inoperable CTEPH and 5 with residual postendarterectomy CTEPH) who underwent 75 BPA procedures performed in a staged manner to reduce complications. The median number of sessions was 2 (interquartile range [IQR], 1-3) per patient, and the number of vessels treated per session was 3 (IQR, 2-3). Of the 31 patients, 24 (77.4%) were taking pulmonary vasodilators and 22 (71.0%) were taking riociguat. The mean pulmonary arterial pressure decreased from 40 mm Hg (IQR, 29-48 mm Hg) to 29 mm Hg (IQR, 25-37 mm Hg;

conclusionOur experience with BPA revealed that this procedure has acceptable risk and improves hemodynamics, functional class, and exercise tolerance in patients with inoperable or residual CTEPH.

Indexed as

6MWD, 6-minute walk distanceBPA, balloon pulmonary angioplastyCTEPH, chronic thromboembolic pulmonary hypertensionICU, intensive care unitIQR, interquartile rangeNT-proBNP, N-terminal pro-B-type natriuretic peptideNYHA, New York Heart AssociationPA, pulmonary arteryPH, pulmonary hypertensionRAP, right atrial pressureRHC, right-sided heart catheterizationRV, right ventricularRVSP, right ventricular systolic pressureTAPSE, tricuspid annular plane systolic excursionWU, Wood units

Identifiers

PMID31485569
PMCPMC6713895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.